Challenger Wealth Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$741K Sell
1,901
-27
-1% -$11.4K 0.55% 35
2026
Q1
$912K Buy
1,928
+9
+0.5% +$4.53K 0.73% 31
2025
Q4
$896K Sell
1,919
-2
-0.1% -$929 0.68% 30
2025
Q3
$819K Sell
1,921
-159
-8% -$61.6K 0.64% 32
2025
Q2
$797K Buy
2,080
+5
+0.2% +$1.8K 0.55% 34
2025
Q1
$717K Sell
2,075
-314
-13% -$101K 0.57% 36
2024
Q4
$717K Buy
+2,389
New +$835K 0.62% 37

Other funds holding HCA

Challenger Wealth Management's HCA Position: Q2 2026 in Review

Challenger Wealth Management reduced its HCA Healthcare (HCA) stake by 1.4% in Q2 2026, selling an estimated $11.4K and leaving 1,901 shares worth $741K. The position accounts for 0.55% of the portfolio, ranked #35.

Challenger Wealth Management first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $912K in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Challenger Wealth Management held 1,901 shares of HCA Healthcare worth $741K as of Q2 2026.
  • Challenger Wealth Management sold 27 HCA Healthcare shares in Q2 2026, an estimated $11.4K.
  • HCA Healthcare made up 0.55% of Challenger Wealth Management's portfolio in Q2 2026, its #35 holding.
  • Challenger Wealth Management first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Challenger Wealth Management's HCA Healthcare position peaked at $912K in Q1 2026.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Challenger Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.